Frank D. Lee
CIK 1814686 · Chief Executive Officer · last filed 2026-05-26
Frank D. Lee is a Chief Executive Officer who has filed 22 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for BHC, was dated May 26, 2026. Across all open-market trades the lifetime net is −$330.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.67M
4
22
-$330.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 95,210 | $5.06 | $481.8K | -$254.7K | 5 | 2026-05-26 |
| PCRX | Chief Executive Officer | 660,830 | $22.99 | $15.19M | $100.0K | 7 | 2026-02-13 |
| BOLT | Director | — | $4.56 | — | $0 | 5 | 2024-06-14 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | President and CEO | 0 | $20.01 | $0 | -$175.8K | 5 | 2022-10-14 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | BHC | Grant (A) | +45,871 | $0 | EDGAR |
| 2026-05-20 | BHC | Sell (S) | −24,456 | -$132.8K | EDGAR |
| 2026-02-13 | PCRX | Grant (A) | +261,818 | $0 | EDGAR |
| 2026-02-03 | PCRX | Tax (F) | −41,488 | -$852.2K | EDGAR |
| 2026-01-06 | PCRX | Tax (F) | −9,272 | -$226.8K | EDGAR |
| 2025-08-22 | BHC | Sell (S) | −15,912 | -$121.9K | EDGAR |
| 2025-05-20 | BHC | Grant (A) | +54,347 | $0 | EDGAR |
| 2025-02-04 | PCRX | Grant (A) | +350,000 | $0 | EDGAR |
| 2025-01-06 | PCRX | Tax (F) | −9,375 | -$171.8K | EDGAR |
| 2024-08-13 | PCRX | Buy (P) | +8,264 | $100.0K | EDGAR |